あすか製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証1部 | 医薬品 | 4514/E00929 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2014/08/22 | 日証協 | 269,140株 | -5.53% | 17,372株 | -59.79% | 255,247株 | -0.46% | 16,800株 | +39.73% |
2014/08/15 | 日証協 | 284,908株 | +2.15% | 43,200株 | -64.83% | 256,424株 | +1.42% | 12,023株 | +21.44% |
2014/08/08 | 日証協 | 278,908株 | +0.65% | 122,816株 | +233.67% | 252,824株 | -1.79% | 9,900株 | +209.38% |
2014/08/01 | 日証協 | 277,108株 | -4.58% | 36,808株 | -4.89% | 257,424株 | -5.12% | 3,200株 | +45.45% |
2014/07/25 | 日証協 | 290,408株 | -7.52% | 38,700株 | -68.97% | 271,324株 | -6.58% | 2,200株 | -93.49% |
2014/07/18 | 日証協 | 314,008株 | -5.31% | 124,700株 | -1.73% | 290,424株 | -11.35% | 33,800株 | -65.55% |
2014/07/11 | 日証協 | 331,608株 | -3.13% | 126,900株 | +92.56% | 327,624株 | +10.53% | 98,100株 | +207.52% |
2014/07/04 | 日証協 | 342,308株 | +6.44% | 65,900株 | -57.43% | 296,424株 | +0.88% | 31,900株 | +262.5% |
2014/06/27 | 日証協 | 321,608株 | -3.59% | 154,808株 | -72.82% | 293,824株 | -14.12% | 8,800株 | -89.91% |
2014/06/20 | 日証協 | 333,578株 | +11.52% | 569,530株 | +117.75% | 342,116株 | +11.24% | 87,208株 | -37.8% |
2014/06/13 | 日証協 | 299,120株 | -1.11% | 261,548株 | +52.53% | 307,558株 | -11.24% | 140,200株 | +17.13% |
2014/06/06 | 日証協 | 302,478株 | -21.88% | 171,475株 | -64.37% | 346,516株 | -15.72% | 119,700株 | -64.6% |
2014/05/30 | 日証協 | 387,211株 | +50.54% | 481,282株 | +144.63% | 411,149株 | +8.58% | 338,100株 | +19.22% |
2014/05/23 | 日証協 | 257,211株 | +30.49% | 196,741株 | +906.81% | 378,649株 | +82.7% | 283,600株 | +1842.47% |
2014/05/16 | 日証協 | 197,111株 | +2.98% | 19,541株 | +231.2% | 207,249株 | +2.83% | 14,600株 | +1227.27% |
2014/05/09 | 日証協 | 191,411株 | +0.95% | 5,900株 | +436.36% | 201,549株 | -0.35% | 1,100株 | +10% |
2014/05/02 | 日証協 | 189,611株 | +0.96% | 1,100株 | -93.33% | 202,249株 | +0.8% | 1,000株 | -64.7% |
2014/04/25 | 日証協 | 187,811株 | +2.9% | 16,500株 | -70.47% | 200,649株 | -1.91% | 2,833株 | 0% |
2014/04/18 | 日証協 | 182,511株 | -8.06% | 55,882株 | -74.45% | 204,549株 | -8.25% | 0株 | -100% |
※株式分割は考慮していませんのでご注意ください。
Page Top